Scenture inks exclusive deal to distribute Rezennopy naloxone
Scenture Holdings (SCNX) entered an exclusive sales, marketing and distribution agreement to offer REZENOPY naloxone 10 mg via a partner network of about 2,000 U.S. OTP and addiction treatment centers.
Story updates
12:22:06 PM UTC
SquawkNews
SCIENTURE HOLDINGS, INC. entered an exclusive sales, marketing and distribution agreement to offer REZENOPY naloxone 10 mg via a partner’s network of approximately 2,000 U.S. OTP and addiction treatment centers. The U.S. naloxone market is about $140M across 9.8M units.Material DetailsContext by AI…